-
Antiplatelet and antithrombotic treatment of patients with peripheral arterial diseasePoredoš, Pavel ; Ježovnik, Mateja, 1979-Platelets and coagulation system play a pivotal part in the progression of peripheral arterial disease (PAD) and the genesis of complications. Therefore,antiplatelet and antithrombotic drugs ... represent one of the basic options for prevention and the treatment in such patients. As the data on the efficacy of these drugs in PAD patients are limited and contradictory, authorsprepared an overview of the literature and recommendations for the use of these drugs. Antiplatelet therapy significantly reduces the incidence of death and cardiovascular events and prevents progression of local disease in PAD patients. Aspirin represents the first-line of antiplatelet drugs. Low-dose aspirin (75-325 mg) is as effective as higher doses. However, higher doses of aspirin result in increased risk of gastrointestinal (GI) bleeding and very low-doses (<75 mg) are less effective. Clopidogrel is used in place of low-dose aspirin in patients who have aspirin-related intolerance or allergy. Combined antiplatelet therapy is slightly more effective than aspirinalone only in patients with a history of established vascular disease. Oral anticoagulant therapy alone or in combination with aspirin was in PAD patients not shown to be more effective than aspirin alone in prevention of cardiovascular events, but is probably more effective in prevention of graft occlusion. However the combination is related to an increased risk of bleeding. Moderate intensity of warfarin treatment would be acceptable in the presence of coexisting indications such as atrial fibrillation or recent venous thrombosis.Vir: International angiology. - ISSN 0392-9590 (Letn. 29, št. 1, 2010, str. 20-26)Vrsta gradiva - članek, sestavni delLeto - 2010Jezik - angleškiCOBISS.SI-ID - 26919641
Avtor
Poredoš, Pavel |
Ježovnik, Mateja, 1979-
Teme
Peripheral Vascular Diseases |
Drug Therapy |
Arterial Occlusive Diseases |
Platelet Aggregation Inhibitors |
Fibrinolytic Agents |
Aspirin |
Warfarin |
Cardiovascular Diseases |
Prevention And Control |
Anticoagulants |
Coronary Disease |
Periferne žile, bolezni |
Trombociti, zlepljenje, inhibitorji |
Fibrinolitiki |
Arterijske, okluzivne bolezni |
Aspirin |
Kardiovaskularne bolezni |
Antikoagulansi |
Koronarna bolezen |
Varfarin
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Poredoš, Pavel | 04548 |
Ježovnik, Mateja, 1979- | 30830 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.